MARKET

GNVR

GNVR

Genvor Inc
OTCMQB
0.014
NaN%
Closed 09:30 02/12 EST
OPEN
--
PREV CLOSE
0.014
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.000
52 WEEK LOW
0.014
MARKET CAP
483.17K
P/E (TTM)
-0.0644
1D
5D
1M
3M
1Y
5Y
1D
Genvor Inc. Appoints Dr. George Stavrides as Executive Vice President
Reuters · 01/28 13:05
GENVOR APPOINTS DR. GEORGE STAVRIDES AS EXECUTIVE VICE PRESIDENT, BUSINESS DEVELOPMENT & COMMERCIALIZATION
Reuters · 01/28 13:05
Genvor Inc. to Present AI-Accelerated Peptide Technology at DealFlow Discovery Conference
Reuters · 01/20 12:01
Genvor Inc. Files Initial Beneficial Ownership Statement; Dr. Jessee M. Jaynes Listed as Director and Chief Research Officer
Reuters · 12/05/2025 21:07
GENVOR AND TUSKEGEE UNIVERSITY ANNOUNCE TEAMING AGREEMENT TO ADVANCE PEPTIDE RESEARCH AND SUSTAINABLE CROP PROTECTION TECHNOLOGIES
Reuters · 12/02/2025 13:00
Genvor Inc. Granted U.S. Patent for Transgenic Corn with Antifungal Peptide AGM182
Reuters · 11/12/2025 13:00
Weekly Report: what happened at GNVR last week (0908-0912)?
Weekly Report · 09/15/2025 12:13
Weekly Report: what happened at GNVR last week (0901-0905)?
Weekly Report · 09/08/2025 12:15
More
About GNVR
Genvor Incorporated is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through biological foliar application as well as transgenic seed traits. The company’s proprietary BioCypher Algorithm combines computational biology, machine learning, and regulatory benchmarks to create peptides that optimize agricultural outcomes with biological safety. With multiple patents and proprietary peptides in active development, it offers ready-to-deploy licensing opportunities that integrate with existing production infrastructure and regulatory frameworks. The Company’s platform centers on the development of anti-microbial peptides (AMPs), which are designed to combat a broad spectrum of debilitating and destructive plant diseases including bacterial, fungal, and viral pathogens that threaten crop productivity worldwide.

Webull offers Genvor Inc stock information, including OTCMQB: GNVR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNVR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNVR stock methods without spending real money on the virtual paper trading platform.